No link between COVID-19 vaccines & sudden deaths: ICMR-AIIMS Study

​Union Minister of Health and Family Welfare said that extensive studies by the Indian Council of Medical Research (ICMR) and All India Institute of Medical Sciences have conclusively established no linkage between COVID-19 vaccines and sudden deaths among adults post-COVID-19.

The Ministry noted that studies conducted by ICMR and the National Centre for Disease Control (NCDC) affirm that COVID-19 vaccines in India are safe and effective, with extremely rare instances of serious side effects. The incidence of sudden cardiac deaths can result from a wide range of factors, including genetics, lifestyle, pre-existing conditions, and post-COVID complications. The ICMR and NCDC have been working together to understand the causes behind sudden, unexplained deaths, especially in young adults between the ages of 18 and 45 years.

Akashvani correspondent reports that to explore this, two complementary studies were undertaken using different research approaches-one based on past data and another involving real-time investigation. The findings of the first study have conclusively shown that COVID-19 vaccination does not increase the risk of unexplained sudden death in young adults. The second study is currently being conducted by AIIMS, New Delhi.

Early analysis indicates that heart attacks, or myocardial infarction, continue to be the leading cause of sudden death in this age group. The studies offer a more comprehensive understanding of sudden unexplained deaths in young adults in India. They also reveal that COVID-19 vaccination does not appear to increase the risk, whereas the role of underlying health issues, genetic predisposition and risky lifestyle choices does play a role in unexplained sudden deaths. Scientific experts have reiterated that statements linking COVID vaccination to sudden deaths are false and misleading, not supported by scientific consensus.

Related Posts

3-month relief: Final call for 10,000 pharmacists to renew registration

At least 70,000 pharmacists are registered in Haryana; of these, about 10,000 — whose registrations expired on December 31, 2020, — have not yet renewed The Haryana State Pharmacy Council…

Marksans Pharma gets USFDA nod for generic Benzonatate capsules

Marksans Pharma Ltd on Wednesday said it has received final approval from the US health regulator for its generic version of Benzonatate capsules indicated for treatment of persistent cough, bronchitis,…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Customs Duty Exemption on Petrochemicals, AiMeD welcomes but Dil ‘Mange More’

Customs Duty Exemption on Petrochemicals, AiMeD welcomes but Dil ‘Mange More’

Sir Ganga Ram Hospital Launches Dialysis Center in Gurgaon for advanced care

Sir Ganga Ram Hospital Launches Dialysis Center in Gurgaon for advanced care

3-month relief: Final call for 10,000 pharmacists to renew registration

3-month relief: Final call for 10,000 pharmacists to renew registration

Marksans Pharma gets USFDA nod for generic Benzonatate capsules

Marksans Pharma gets USFDA nod for generic Benzonatate capsules

Greatest Defender of Consumer Rights doesn’t like Sound of Patient as ‘GRAHAK’

Greatest Defender of Consumer Rights doesn’t like Sound of Patient as ‘GRAHAK’

Roche launches the cobas MPX-E assay, a new 4-in-1 donor screening test

Roche launches the cobas MPX-E assay, a new 4-in-1 donor screening test